Willis Knighton Health is First Center of Excellence for Robotic-Assisted Bronchoscopy in Louisiana, Third in U.S.
November 16, 2026Willis Knighton Health is the first health organization in Louisiana and the third in the United States to earn Center of Excellence for Robotic-Assisted Bronchoscopy. The accreditation from Surgical Review Corporation recognizes hospitals and surgeons that meet the highest standards for quality patient care and safety in robotic-assisted bronchoscopy – a minimally invasive procedure that uses advanced robotic technology to diagnose lung cancer and other pulmonary conditions.
To achieve this elite designation, applicants must demonstrate compliance with strict criteria, including required surgical volumes, advanced facility equipment, structured clinical pathways and standardized operating procedures. The evaluation heavily emphasizes robust patient education and continuous quality assessment. Throughout this comprehensive process, expert inspectors actively train and align department staff with global best practices, directly elevating the organization's care, safety, and service delivery.
Willis Knighton pulmonologists Ahmed Virani, MD, and Kamal A. Masri, MD, are designated surgeons of excellence.
“This recognition reflects our team’s dedication to delivering high-quality care and advancing the early diagnosis of lung cancer through robotic technology. Early detection saves lives,” Dr. Virani said.
“This technology allows us to offer world class pulmonary care right here in Northwest Louisiana,” Dr. Masri added.
Robotic-assisted bronchoscopy allows physicians to look inside the airways and take small tissue samples from areas that are hard to reach with traditional bronchoscopy methods. During the procedure, a thin, flexible and steerable catheter is guided through the airways along a carefully planned path, using a camera and navigation system. This technique is designed to improve the accuracies of biopsies for small or deep lung nodules, while reducing the need for more invasive procedures. This expedites the diagnosis process for patients which improves patient outcomes.
According to the American Lung Association, lung cancer remains the leading cause of cancer deaths in the United States for both men and women. The five-year survival rate is much higher if caught at an early, localized stage, yet only about 28.1 percent of cases are diagnosed early.
Willis Knighton Health is First Center of Excellence for Robotic-Assisted Bronchoscopy in Louisiana, Third in U.S.
November 16, 2026Willis Knighton Health is the first health organization in Louisiana and the third in the United States to earn Center of Excellence for Robotic-Assisted Bronchoscopy. The accreditation from Surgical Review Corporation recognizes hospitals and surgeons that meet the highest standards for quality patient care and safety in robotic-assisted bronchoscopy – a minimally invasive procedure that uses advanced robotic technology to diagnose lung cancer and other pulmonary conditions.
To achieve this elite designation, applicants must demonstrate compliance with strict criteria, including required surgical volumes, advanced facility equipment, structured clinical pathways and standardized operating procedures. The evaluation heavily emphasizes robust patient education and continuous quality assessment. Throughout this comprehensive process, expert inspectors actively train and align department staff with global best practices, directly elevating the organization's care, safety, and service delivery.
Willis Knighton pulmonologists Ahmed Virani, MD, and Kamal A. Masri, MD, are designated surgeons of excellence.
“This recognition reflects our team’s dedication to delivering high-quality care and advancing the early diagnosis of lung cancer through robotic technology. Early detection saves lives,” Dr. Virani said.
“This technology allows us to offer world class pulmonary care right here in Northwest Louisiana,” Dr. Masri added.
Robotic-assisted bronchoscopy allows physicians to look inside the airways and take small tissue samples from areas that are hard to reach with traditional bronchoscopy methods. During the procedure, a thin, flexible and steerable catheter is guided through the airways along a carefully planned path, using a camera and navigation system. This technique is designed to improve the accuracies of biopsies for small or deep lung nodules, while reducing the need for more invasive procedures. This expedites the diagnosis process for patients which improves patient outcomes.
According to the American Lung Association, lung cancer remains the leading cause of cancer deaths in the United States for both men and women. The five-year survival rate is much higher if caught at an early, localized stage, yet only about 28.1 percent of cases are diagnosed early.





